6PIV
Crystal structure of HCV NS3/4A D168A protease in complex with P4-7 (NR03-77)
6PIV の概要
エントリーDOI | 10.2210/pdb6piv/pdb |
分子名称 | NS3/4A protease, ZINC ION, (1R,3r,5S)-bicyclo[3.1.0]hexan-3-yl [(2R,6S,12Z,13aS,14aR,16aS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14a-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl]carbamate, ... (6 entities in total) |
機能のキーワード | ns3/4a protease, hepatitis c virus, drug resistance, protease inhibitor, hydrolase-hydrolase inhibitor complex, hydrolase, hydrolase/hydrolase inhibitor |
由来する生物種 | Hepacivirus C |
タンパク質・核酸の鎖数 | 1 |
化学式量合計 | 24475.01 |
構造登録者 | |
主引用文献 | Matthew, A.N.,Zephyr, J.,Nageswara Rao, D.,Henes, M.,Kamran, W.,Kosovrasti, K.,Hedger, A.K.,Lockbaum, G.J.,Timm, J.,Ali, A.,Kurt Yilmaz, N.,Schiffer, C.A. Avoiding Drug Resistance by Substrate Envelope-Guided Design: Toward Potent and Robust HCV NS3/4A Protease Inhibitors. Mbio, 11:-, 2020 Cited by PubMed: 32234812DOI: 10.1128/mBio.00172-20 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.14 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード